(Q77959586)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

J Vincent

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

T Hunt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

R Teng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

L Robarge

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

S A Willavize

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

H L Friedman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

English

0 references

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Surgery

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

6A Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

32S-38S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

Quinolone antibacterials. An update of their pharmacology and therapeutic use.

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

In vitro activity of the new fluoroquinolone CP-99,219.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

Mechanisms of Fluoroquinolone Resistance in Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

In vitro antimicrobial activity of CP-99,219, a new 7-azabicyclonaphthyridone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against gram-positive cocci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

7 January 2021

Anaerobic infections. 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

Oral bioavailability of trovafloxacin with and without food in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

Pharmacokinetics of orally administered ciprofloxacin in abdominal surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

The chemistry and biological profile of trovafloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900218-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9610(98)00218-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9935255%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference